Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2022. Go to the latest filing (Q3 2026)

19.9B USDQ4 2022
Total value of stock positions
19.9B USD
Positions
75
Share of the ten largest
41.8%

The ten largest positions Q4 2022

  1. Visa Inc. 6.0%▲ +8.2%
  2. Amazon 5.3%▲ +34.4%
  3. Elevance Health 4.8%▼ −19.9%
  4. McKesson Corporation 4.2%▼ −15.5%
  5. Microsoft 4.1%▼ −2.3%
  6. Chubb Limited 4.0%▼ −0.4%
  7. Roivant Sciences Ltd 3.5%unchanged
  8. UnitedHealth Group 3.4%▲ +263.7%
  9. GE Aerospace 3.3%▼ −39.6%
  10. Api Group Corp 3.2%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2022

Positions Q4 2022 per 13F filing, 21 of 21
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 5.3% 12,481,958 1.0B USD +34.4% increased Q2 2015 31 quarters
V Visa Inc. 6.0% 5,784,971 1.2B USD +8.2% increased Q3 2016 26 quarters
Molina Healthcare Inc 1.0% 588,208 194.2M USD +44.6% increased Q3 2019 14 quarters
Guardant Health Inc 0.6% 4,107,644 111.7M USD +7.1% increased Q3 2019 14 quarters
TMO Thermo Fisher Scientific 2.3% 839,526 462.3M USD +41.4% increased Q2 2020 11 quarters
Karuna Therapeutics Inc 1.2% 1,183,736 232.6M USD +16.7% increased Q3 2020 10 quarters
Inhibrx Inc 0.8% 6,639,199 163.6M USD +25.1% increased Q3 2020 10 quarters
Acadia Healthcare Company In 1.3% 3,161,114 260.2M USD +6.8% increased Q4 2020 9 quarters
Pharvaris N V 0.2% 3,231,923 36.4M USD +29.4% increased Q1 2021 8 quarters
Intellia Therapeutics Inc 0.4% 2,021,410 70.5M USD +7.0% increased Q2 2021 7 quarters
Biomarin Pharmaceutical Inc 2.7% 5,273,620 545.8M USD +3.4% increased Q4 2021 5 quarters
BEKE KE Holdings 0.6% 8,084,334 112.9M USD +107.6% increased Q4 2021 5 quarters
INTU Intuit 2.3% 1,181,697 459.9M USD +2.1% increased Q2 2022 3 quarters
MU Micron Technology 2.1% 8,358,708 417.8M USD +54.4% increased Q2 2022 3 quarters
Rh 1.0% 748,344 200.0M USD +80.4% increased Q2 2022 3 quarters
Shockwave Med Inc 0.2% 164,607 33.8M USD +4.6% increased Q2 2022 3 quarters
UNH UnitedHealth Group 3.4% 1,267,703 672.1M USD +263.7% increased Q3 2022 2 quarters
Rogers Comms B 1.0% 4,375,144 204.8M USD +29.5% increased Q3 2022 2 quarters
CDNS Cadence Design Systems 0.9% 1,134,301 182.2M USD +87.3% increased Q3 2022 2 quarters
CLX Clorox 0.5% 768,839 107.9M USD +26.7% increased Q3 2022 2 quarters
CRWD CrowdStrike 0.4% 699,948 73.7M USD +146.2% increased Q3 2022 2 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 75.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 75.2M USD

Breakdown by sector

  • Financials 18.0%
  • Health Care 17.9%
  • Technology 12.2%
  • Industrials 7.9%
  • Consumer Discretionary 5.3%
  • Communication Services 1.4%
  • Consumer Staples 0.9%
  • Materials 0.6%
  • not in our coverage 35.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close